OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
50600356

Fullgoal Science and Technology Innovation Board 2 Year Regularly Open Mixed Securities Investment Fund

Closed End FundsVerified

The fund’s capital structure is defined by 229,169,200 basic and diluted shares outstanding, indicating no dilution risk in the current reporting period. However, liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The valuation snapshot is currently empty, suggesting a lack of recent financial disclosures or market activity to inform key ratios. Profitability and returns cannot be evaluated against industry_config preferred metrics or cohort medians due to the absence of financial performance data in the valuation snapshot. The fund’s performance benchmark and its ability to outperform are not quantified in the available data, limiting the ability to assess its competitive positioning. The fund’s geographic and segment exposure is not disclosed in the input data, preventing an analysis of revenue concentration or diversification. Without segment-level or geographic revenue breakdowns, it is impossible to determine whether the fund is overexposed to any particular market or asset class. Growth trajectory is also indeterminate, as the outlook section lacks numeric deltas or revenue history. The fund’s 2-year open structure implies a medium-term investment horizon, but no forward-looking guidance is provided in the input data. Risk factors include the inability to assess liquidity risk, which is flagged as a key concern in the risk assessment. The fund’s dilution risk is currently low, but the absence of adjustments_applied in custom_valuations suggests no recent capital events or share issuance. Recent events, such as filings or transcripts, are not included in the input data, leaving the fund’s operational and strategic developments opaque. The lack of source documents beyond the financial snapshot limits the ability to infer recent management actions or market positioning.

30-day price · 506003+0.27 (+30.7%)
Low$0.88High$1.20Close$1.15As of15 May, 00:00 UTC
Profile
CompanyFullgoal Science and Technology Innovation Board 2 Year Regularly Open Mixed Securities Investment Fund
Ticker506003.SS
SectorFinancials
BusinessCollective Investments
Industry groupCollective Investments
IndustryClosed End Funds
AI analysis

Business. Fullgoal Science and Technology Innovation Board 2 Year Regularly Open Mixed Securities Investment Fund is a hybrid securities investment fund managed by Fullgoal Fund Management Co Ltd, seeking to generate returns for shareholders by outperforming its performance benchmark.

Classification. The fund is classified under the Financials economic sector, Collective Investments business sector, and Closed End Funds industry, with a confidence level of 0.92 based on verified market data.

The fund’s capital structure is defined by 229,169,200 basic and diluted shares outstanding, indicating no dilution risk in the current reporting period. However, liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The valuation snapshot is currently empty, suggesting a lack of recent financial disclosures or market activity to inform key ratios. Profitability and returns cannot be evaluated against industry_config preferred metrics or cohort medians due to the absence of financial performance data in the valuation snapshot. The fund’s performance benchmark and its ability to outperform are not quantified in the available data, limiting the ability to assess its competitive positioning. The fund’s geographic and segment exposure is not disclosed in the input data, preventing an analysis of revenue concentration or diversification. Without segment-level or geographic revenue breakdowns, it is impossible to determine whether the fund is overexposed to any particular market or asset class. Growth trajectory is also indeterminate, as the outlook section lacks numeric deltas or revenue history. The fund’s 2-year open structure implies a medium-term investment horizon, but no forward-looking guidance is provided in the input data. Risk factors include the inability to assess liquidity risk, which is flagged as a key concern in the risk assessment. The fund’s dilution risk is currently low, but the absence of adjustments_applied in custom_valuations suggests no recent capital events or share issuance. Recent events, such as filings or transcripts, are not included in the input data, leaving the fund’s operational and strategic developments opaque. The lack of source documents beyond the financial snapshot limits the ability to infer recent management actions or market positioning.
Key takeaways
  • The fund has no dilution risk in the current reporting period, with basic and diluted shares outstanding equal at 229,169,200.
  • Liquidity risk cannot be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
  • No financial performance data is available to evaluate profitability or returns against industry benchmarks.
  • Geographic and segment exposure is undisclosed, limiting visibility into diversification and concentration risk.
  • Growth trajectory and forward-looking guidance are absent from the input data.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Closed End Funds · cohort 11 companies
Metric506003Activity
Op margin55.6% medp25 35.9% · p75 83.7%
Net margin54.5% medp25 -2.5% · p75 86.3%
Gross margin67.0% medp25 47.0% · p75 89.7%
CapEx / revenue-3.8% medp25 -7.7% · p75 -0.6%
Debt / equity7.0% medp25 0.0% · p75 77.9%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 17:40 UTC#efc89c30
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 13:39 UTCJob: d830e4d8